Advancing CAR T-cell therapies: Preclinical insights and clinical translation for hematological malignancies.

导出 LinkOut

翻译打印收藏纠错

作者： Arun K,Arunachalam ^[1] ; Céline,Grégoire ^[1] ; Beatriz,Coutinho de Oliveira ^[1] ; Jan Joseph,Melenhorst ^[2]

作者单位： Cell Therapy & Immuno-Engineering Program, Center for Immunotherapy and Precision Immuno-Oncology, Lerner College of Medicine, Cleveland Clinic, Cleveland, OH 44195, United States of America. ^[1] Cell Therapy & Immuno-Engineering Program, Center for Immunotherapy and Precision Immuno-Oncology, Lerner College of Medicine, Cleveland Clinic, Cleveland, OH 44195, United States of America. Electronic address: melenhj@ccf.org. ^[2]

关键词 CAR T-cells Hematological malignancies Long-term remissions Preclinical studies Predictors of response Translational immunology

主题词人类(Humans);免疫疗法, 过继(Immunotherapy, Adoptive);血液肿瘤(Hematologic Neoplasms);动物(Animals);T淋巴细胞(T-Lymphocytes);疾病模型, 动物(Disease Models, Animal);受体, 抗原, T细胞(Receptors, Antigen, T-Cell)

DOI 10.1016/j.blre.2024.101241

PMID 39289094

发布时间 2024-11-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交